Host
E Coli or Yeast or Baculovirus or Mammalian Cell
Purity/Purification
Greater or equal to 85% purity as determined by SDS-PAGE.
Form/Format
Lyophilized or liquid (Format to be determined during the manufacturing process)
Sequence Positions
21-396aa; Full Length
Sequence
EVSADQVATVMWDYFSQLSNNAKEAVEHLQKSELTQQLNALFQDKLGEVNTYAGDLQKKLVPFATELHERLAKDSEKLKEEIGKELEELRARLLPHANEVSQKIGDNLRELQQRLEPYADQLRTQVNTQAEQLRRQLTPYAQRMERVLRENADSLQASLRPHADELKAKIDQNVEELKGRLTPYADEFKVKIDQTVEELRRSLAPYAQDTQEKLNHQLEGLTFQMKKNAEELKARISASAEELRQRLAPLAEDVRGNLRGNTEGLQKSLAELGGHLDQQVEEFRRRVEPYGENFNKALVQQMEQLRQKLGPHAGDVEGHLSFLEKDLRDKVNSFFSTFKEKESQDKTLSLPELEQQQEQQQEQQQEQVQMLAPLES
Sequence Length
396
Preparation and Storage
Store at -20 degree C, for extended storage, conserve at -20 degree C or -80 degree C.
Related Product Information for APOA4 recombinant protein
May have a role in chylomicrons and VLDL secretion and catabolism. Required for efficient activation of lipoprotein lipase by ApoC-II; potent activator of LCAT. Apoa-IV is a major component of HDL and chylomicrons.
Product Categories/Family for APOA4 recombinant protein
References
Structure, evolution, and tissue-specific synthesis of human apolipoprotein AIV.Karathanasis S.K., Yunis I.Biochemistry 25:3962-3970(1986) Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4) .Karathanasis S.K., Oettgen P., Haddad I.A., Antonarakis S.E.Proc. Natl. Acad. Sci. U.S.A. 83:8457-8461(1986) Structure and expression of the human apolipoprotein A-IV gene.Elshourbagy N.A., Walker D.W., Paik Y.K., Boguski M.S., Freeman M., Gordon J.I., Taylor J.M.J. Biol. Chem. 262:7973-7981(1987) The primary structure of human apolipoprotein A-IV.Yang C., Gu Z.W., Xiong W., Rosseneu M., Yang H.X., Lee B.M., Gotto A.M. Jr., Chan L.Biochim. Biophys. Acta 1002:231-237(1989) The effects of scale variation in the APOA1/C3/A4/A5 gene cluster.Fullerton S.M., Buchanan A.V., Sonpar V.A., Taylor S.L., Smith J.D., Carlson C.S., Salomaa V., Stengaard J.H., Boerwinkle E., Clark A.G., Nickerson D.A., Weiss K.M.Hum. Genet. 115:36-56(2004) Human chromosome 11 DNA sequence and analysis including novel gene identification.Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S., Sakaki Y.Nature 440:497-500(2006) The nucleotide and derived amino acid sequence of human apolipoprotein A-IV mRNA and the close linkage of its gene to the genes of apolipoproteins A-I and C-III.Elshourbagy N.A., Walker D.W., Boguski M.S., Gordon J.I., Taylor J.M.J. Biol. Chem. 261:1998-2002(1986) Biosynthesis of human preapolipoprotein A-IV.Gordon J.I., Bisgaier C.L., Sims H.F., Sachdev O.P., Glickman R.M., Strauss A.W.J. Biol. Chem. 259:468-474(1984) Genetic polymorphism of apolipoprotein A-IV.Lohse P., Brewer H.B. Jr.Curr. Opin. Lipidol. 2:90-95(1991) Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene.Lohse P., Kindt M.R., Rader D.J., Brewer H.B. Jr.J. Biol. Chem. 265:10061-10064(1990) Human plasma apolipoproteins A-IV-0 and A-IV-3. Molecular basis for two rare variants of apolipoprotein A-IV-1.Lohse P., Kindt M.R., Rader D.J., Brewer H.B. Jr.J. Biol. Chem. 265:12734-12739(1990) Initial characterization of the human central proteome.Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.BMC Syst. Biol. 5:17-17(2011) The structure of dimeric apolipoprotein A-IV and its mechanism of self-association.Deng X., Morris J., Dressmen J., Tubb M.R., Tso P., Jerome W.G., Davidson W.S., Thompson T.B.Structure 20:767-779(2012) The mutation causing the common apolipoprotein A-IV polymorphism is a glutamine to histidine substitution of amino acid 360.Tenkanen H., Lukka M., Jauhiainen M., Metso J., Baumann M., Peltonen L., Ehnholm C.Arterioscler. Thromb. 11:851-856(1991) Three genetic variants of human plasma apolipoprotein A-IV apoA-IV-1(Thr-347-->Ser) , apoA-IV-0(Lys-167-->Glu,Gln-360-->His) , and apoA-IV-3(Glu-165-->Lys) .Lohse P., Kindt M.R., Rader D.J., Brewer H.B. Jr.J. Biol. Chem. 266:13513-13518(1991) ErratumLohse P., Kindt M.R., Rader D.J., Brewer H.B. Jr.J. Biol. Chem. 266:19866-19866(1991) Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.von Eckardstein A., Funke H., Schulte M., Erren M., Schulte H., Assmann G.Am. J. Hum. Genet. 50:1115-1128(1992) A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127.Tenkanen H., Koskinen P., Metso J., Baumann M., Lukka M., Kauppinen-Makelin R., Kontula K., Taskinen M.R., Manttari M., Manninen V., Ehnholm C.Biochim. Biophys. Acta 1138:27-33(1992) Molecular basis of a unique African variant (A-IV 5) of human apolipoprotein A-IV and its significance in lipid metabolism.Kamboh M.I., Williams E.R., Law J.C., Aston C.E., Bunker C.H., Ferrell R.E., Pollitzer W.S.Genet. Epidemiol. 9:379-388(1992) Apolipoprotein A-IV polymorphism in the Hungarian population gene frequencies, effect on lipid levels, and sequence of two new variants.Menzel H.J., Dieplinger H., Sandholzer C., Karadi I., Utermann G., Csaszar A.Hum. Mutat. 5:58-65(1995) Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.Deeb S.S., Nevin D.N., Iwasaki L., Brunzell J.D.3.3.CO;2-T>Hum. Mutat. 8:319-325(1996) Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis.Halushka M.K., Fan J.-B., Bentley K., Hsie L., Shen N., Weder A., Cooper R., Lipshutz R., Chakravarti A.Nat. Genet. 22:239-247(1999) An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., Ye M., Zou H.J. Proteomics 96:253-262(2014)
NCBI and Uniprot Product Information
Similar Products
Product Notes
The APOA4 apoa4 (Catalog #AAA114329) is a Recombinant Protein produced from E Coli or Yeast or Baculovirus or Mammalian Cell and is intended for research purposes only. The product is available for immediate purchase. The immunogen sequence is 21-396aa; Full Length. The amino acid sequence is listed below: EVSADQVATV MWDYFSQLSN NAKEAVEHLQ KSELTQQLNA LFQDKLGEVN TYAGDLQKKL VPFATELHER LAKDSEKLKE EIGKELEELR ARLLPHANEV SQKIGDNLRE LQQRLEPYAD QLRTQVNTQA EQLRRQLTPY AQRMERVLRE NADSLQASLR PHADELKAKI DQNVEELKGR LTPYADEFKV KIDQTVEELR RSLAPYAQDT QEKLNHQLEG LTFQMKKNAE ELKARISASA EELRQRLAPL AEDVRGNLRG NTEGLQKSLA ELGGHLDQQV EEFRRRVEPY GENFNKALVQ QMEQLRQKLG PHAGDVEGHL SFLEKDLRDK VNSFFSTFKE KESQDKTLSL PELEQQQEQQ QEQQQEQVQM LAPLES. It is sometimes possible for the material contained within the vial of "Apolipoprotein A-IV, Recombinant Protein" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
